The Prognostic Utility of Cytokines in Hospitalized COVID-19 Patients

1. Dhar SK, K V, Damodar S, Gujar S, Das M. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon. 2021;7(2):e06155. DharSK KV DamodarS GujarS DasM IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression Heliyon 2021 7 2 e06155 Search in Google Scholar

2. Worldometer. Coronavirus statistics. Available from: https://www.worldometers.info/coronavirus/ [Accessed 31 August 2022] Worldometer Coronavirus statistics Available from: https://www.worldometers.info/coronavirus/ [Accessed 31 August 2022] Search in Google Scholar

3. Sabaka P, Koščálová A, Straka I, et al. Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak. BMC Infect Dis. 2021;21(1):308. SabakaP KoščálováA StrakaI Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak BMC Infect Dis 2021 21 1 308 Search in Google Scholar

4. Santa Cruz A, Mendes-Frias A, Oliveira AI, et al. Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia. Front Immunol. 2021;12.613422. Santa CruzA Mendes-FriasA OliveiraAI Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia Front Immunol 2021 12 613422 Search in Google Scholar

5. Oi Y, Ogawa F, Yamashiro T, et al. Prediction of prognosis in patients with severe COVID-19 pneumonia using CT score by emergency physicians: a single-center retrospective study. Sci Rep. 2023;13(1):4045. OiY OgawaF YamashiroT Prediction of prognosis in patients with severe COVID-19 pneumonia using CT score by emergency physicians: a single-center retrospective study Sci Rep 2023 13 1 4045 Search in Google Scholar

6. Pons MJ, Ymaña B, Mayanga-Herrera A, Sáenz Y, Alvarez-Erviti L, Tapia-Rojas S, et al. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort. Front Immunol. 2021;12:700921. PonsMJ YmañaB Mayanga-HerreraA SáenzY Alvarez-ErvitiL Tapia-RojasS Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort Front Immunol 2021 12 700921 Search in Google Scholar

7. Lu L, Zhang H, Dauphars DJ, He YW. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis. Trends in Immunology. 2021;42:3–5. LuL ZhangH DaupharsDJ HeYW A Potential Role of Interleukin 10 in COVID-19 Pathogenesis Trends in Immunology 2021 42 3 5 Search in Google Scholar

8. Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):92. MontazersahebS Hosseiniyan KhatibiSM HejaziMS COVID-19 infection: an overview on cytokine storm and related interventions Virol J 2022 19 1 92 Search in Google Scholar

9. Basheer M, Saad E, Assy N. The Cytokine Storm in COVID-19: The Strongest Link to Morbidity and Mortality in the Current Epidemic. COVID. 2022;2(5):540–52. BasheerM SaadE AssyN The Cytokine Storm in COVID-19: The Strongest Link to Morbidity and Mortality in the Current Epidemic COVID 2022 2 5 540 52 Search in Google Scholar

10. Bonnet B, Cosme J, Dupuis C, et al. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. EBioMedicine. 2021;73:103622. BonnetB CosmeJ DupuisC Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation EBioMedicine 2021 73 103622 Search in Google Scholar

11. Kuri-Cervantes L, Pampena MB, Meng W, et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. 2020;5(49).eabd7114. Kuri-CervantesL PampenaMB MengW Comprehensive mapping of immune perturbations associated with severe COVID-19 Sci Immunol 2020 5 49 eabd7114 Search in Google Scholar

12. Schulte-Schrepping J, Reusch N, Paclik D, et al. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020;182(6):1419–40. Schulte-SchreppingJ ReuschN PaclikD Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Cell 2020 182 6 1419 40 Search in Google Scholar

13. Li J, Rong L, Cui R, et al. Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19. Ann Palliat Med. 2021;10(4):3706–14. LiJ RongL CuiR Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19 Ann Palliat Med 2021 10 4 3706 14 Search in Google Scholar

14. Pons MJ, Ymaña B, Mayanga-Herrera A, et al. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort. Front Immunol. 2021;12:700921. PonsMJ YmañaB Mayanga-HerreraA Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort Front Immunol 2021 12 700921 Search in Google Scholar

15. del Valle-Mendoza J, Tarazona-Castro Y, Merino-Luna A, et al. Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude. BMC Infect Dis. 2022;22:96. del Valle-MendozaJ Tarazona-CastroY Merino-LunaA Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude BMC Infect Dis 2022 22 96 Search in Google Scholar

16. Ramasamy S, Subbian S. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. Clin Microbiol Rev. 2021;34(3):e00299–20. RamasamyS SubbianS Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis Clin Microbiol Rev 2021 34 3 e00299 20 Search in Google Scholar

17. Shekhawat J, Gauba K, Gupta S, et al. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm. Indian J Clin Biochem. 2021;36(4):440–50. ShekhawatJ GaubaK GuptaS Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm Indian J Clin Biochem 2021 36 4 440 50 Search in Google Scholar

18. Mazaheri T, Ranasinghe R, Al-Hasani W, et al. A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients. PLoS One. 2022;17(5):e0266652. MazaheriT RanasingheR Al-HasaniW A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients PLoS One 2022 17 5 e0266652 Search in Google Scholar

19. Lampart M, Zellweger N, Bassetti S, et al. Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study. PLoS One. 2022;17(5):e0269005. LampartM ZellwegerN BassettiS Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study PLoS One 2022 17 5 e0269005 Search in Google Scholar

20. Rahayu R, Winarto W, Nasihun T. Interleukin-6 and C-reactive Protein on Admission as Predictor of Mortality in Severe COVID-19 Patients: A Retrospective Cohort Study. Open Access Maced J Med Sci. 2022;10(B):227–31. RahayuR WinartoW NasihunT Interleukin-6 and C-reactive Protein on Admission as Predictor of Mortality in Severe COVID-19 Patients: A Retrospective Cohort Study Open Access Maced J Med Sci 2022 10 B 227 31 Search in Google Scholar

21. Brennan K, Zheng J. Interleukin 8. In Enna SJ, Bylund DB (eds): xPharm: The Comprehensive Pharmacology Reference. Amsterdam: Elsevier. 2007, p. 1–4. BrennanK ZhengJ Interleukin 8 In EnnaSJ BylundDB (eds): xPharm: The Comprehensive Pharmacology Reference Amsterdam Elsevier 2007 1 4 Search in Google Scholar

22. Li L, Li J, Gao M, et al. Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients. Front Immunol. 2021;11:602395. LiL LiJ GaoM Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients Front Immunol 2021 11 602395 Search in Google Scholar

23. Cesta MC, Zippoli M, Marsiglia C, et al. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome. Front Pharmacol. 2022;12:808797. CestaMC ZippoliM MarsigliaC The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome Front Pharmacol 2022 12 808797 Search in Google Scholar

24. Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. BarnesBJ AdroverJM Baxter-StoltzfusA Targeting potential drivers of COVID-19: Neutrophil extracellular traps J Exp Med 2020 217 6 e20200652 Search in Google Scholar

25. Islam H, Chamberlain TC, Mui AL, Little JP. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front Immunol. 2021;12:677008. IslamH ChamberlainTC MuiAL LittleJP Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front Immunol 2021 12 677008 Search in Google Scholar

26. Diao B, Wang C, Tan Y, et al. Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020;11:827. DiaoB WangC TanY Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19) Front Immunol 2020 11 827 Search in Google Scholar

27. Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology. 2022;30(3):789–98. HasanvandA COVID-19 and the role of cytokines in this disease Inflammopharmacology 2022 30 3 789 98 Search in Google Scholar

28. Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–30. HanH MaQ LiC Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors Emerg Microbes Infect 2020 9 1 1123 30 Search in Google Scholar

29. Nagant C, Ponthieux F, Smet J, et al. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. Int J Infect Dis. 2020;101:342–5. NagantC PonthieuxF SmetJ A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer Int J Infect Dis 2020 101 342 5 Search in Google Scholar

30. Gotluru C, Roach A, Cherry SH, Runowicz CD. Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity. Obstet Gynecol. 2021;137(3):423–9. GotluruC RoachA CherrySH RunowiczCD Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity Obstet Gynecol 2021 137 3 423 9 Search in Google Scholar

31. Bigdelou B, Sepand MR, Najafikhoshnoo S, et al. COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. Front Immunol. 2022;13:890517. BigdelouB SepandMR NajafikhoshnooS COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes Front Immunol 2022 13 890517 Search in Google Scholar

32. Qin L, Li X, Shi J, et al. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan. J Med Virol. 2020;92(11):2684–92. QinL LiX ShiJ Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan J Med Virol 2020 92 11 2684 92 Search in Google Scholar

33. Queiroz MAF, Neves PFM das, Lima SS, et al. Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome. Front Cell Infect Microbiol. 2022;12:922422. QueirozMAF NevesPFM das LimaSS Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome Front Cell Infect Microbiol 2022 12 922422 Search in Google Scholar

34. Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 2021;11:571416. BajajV GadiN SpihlmanAP WuSC ChoiCH MoultonVR Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol 2021 11 571416 Search in Google Scholar

35. Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections. Obesity Reviews. 2015;16(12):1017–29. DhurandharNV BaileyD ThomasD Interaction of obesity and infections Obesity Reviews 2015 16 12 1017 29 Search in Google Scholar

36. Kim J, Bajaj M. Normal Adipose Tissue Biology: Adipocytokines and Inflammation. In McManus LM, Mitchell R (eds): Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Amsterdam: Elsevier. 2014, p. 488–97. KimJ BajajM Normal Adipose Tissue Biology: Adipocytokines and Inflammation In McManusLM MitchellR (eds): Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms Amsterdam Elsevier 2014 488 97 Search in Google Scholar

37. Guo J, Wang S, Xia H, et al. Cytokine Signature Associated With Disease Severity in COVID-19. Front Immunol. 2021;12:681516. GuoJ WangS XiaH Cytokine Signature Associated With Disease Severity in COVID-19 Front Immunol 2021 12 681516 Search in Google Scholar

38. Liu QQ, Cheng A, Wang Y, et al. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study. BMJ Open. 2020;10(11):e041471. LiuQQ ChengA WangY Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study BMJ Open 2020 10 11 e041471 Search in Google Scholar

39. Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718–24. HadjadjJ YatimN BarnabeiL Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Science 2020 369 6504 718 24 Search in Google Scholar

40. Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020;11:1446. RagabD Salah EldinH TaeimahM KhattabR SalemR The COVID-19 Cytokine Storm; What We Know So Far Front Immunol 2020 11 1446 Search in Google Scholar

41. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. MehtaP McAuleyDF BrownM SanchezE TattersallRS MansonJJ COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 2020 395 10229 1033 4 Search in Google Scholar

42. Cifaldi L, Prencipe G, Caiello I, et al. Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome. Arthritis Rheumatol. 2015;67(11):3037–46. CifaldiL PrencipeG CaielloI Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome Arthritis Rheumatol 2015 67 11 3037 46 Search in Google Scholar

43. Isabel García-Laorden M, Lorente JA, Flores C, Slutsky AS, Villar J. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Transl Med. 2017;5(14):283. Isabel García-LaordenM LorenteJA FloresC SlutskyAS VillarJ Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise Ann Transl Med 2017 5 14 283 Search in Google Scholar

44. Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517–20. LiH LiuL ZhangD SARS-CoV-2 and viral sepsis: observations and hypotheses Lancet 2020 395 10235 1517 20 Search in Google Scholar

45. Zhou J, He W, Liang J, et al. Association of Interleukin-6 Levels with Morbidity and Mortality in Patients with Coronavirus Disease 2019 (COVID-19). Jpn J Infect Dis 2021;74(4):293–8. ZhouJ HeW LiangJ Association of Interleukin-6 Levels with Morbidity and Mortality in Patients with Coronavirus Disease 2019 (COVID-19) Jpn J Infect Dis 2021 74 4 293 8 Search in Google Scholar